Sun Pharma shares in focus after ₹3,000 crore greenfield capacity expansion plan in Madhya Pradesh

Last month, Sun Pharma’s chief financial officer Jayashree Satagopan told CNBC-TV18 that the pharma firm expects its India business to continue growing ahead of the market, supported by a strong focus on key therapies and brand building.

Leave a Reply

Your email address will not be published. Required fields are marked *